<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Halbrook M</submitter><funding>the Bill and Melinda Gates Foundation</funding><pagination>246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10975469</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(3)</volume><pubmed_abstract>Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41.1% (38.0-44.2%), and 38.0% (34.9-41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities-79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.</pubmed_abstract><journal>Vaccines</journal><pubmed_title>Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative.</pubmed_title><pmcid>PMC10975469</pmcid><funding_grant_id>OPP106684</funding_grant_id><pubmed_authors>Kambamba Nzaji M</pubmed_authors><pubmed_authors>Mukadi P</pubmed_authors><pubmed_authors>Ngoie-Mwamba G</pubmed_authors><pubmed_authors>Halbrook M</pubmed_authors><pubmed_authors>Fuller T</pubmed_authors><pubmed_authors>Rimoin AW</pubmed_authors><pubmed_authors>Gerber SK</pubmed_authors><pubmed_authors>Spencer D</pubmed_authors><pubmed_authors>Musene K</pubmed_authors><pubmed_authors>Nyembwe M</pubmed_authors><pubmed_authors>Dzogang C</pubmed_authors><pubmed_authors>Muyembe-Tamfum JJ</pubmed_authors><pubmed_authors>Mbala P</pubmed_authors><pubmed_authors>Kaba D</pubmed_authors><pubmed_authors>Hoff NA</pubmed_authors><pubmed_authors>Tangney S</pubmed_authors><pubmed_authors>Gadoth A</pubmed_authors><pubmed_authors>Sinai CS</pubmed_authors><pubmed_authors>Salet F</pubmed_authors><pubmed_authors>Tambu M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative.</name><description>Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41.1% (38.0-44.2%), and 38.0% (34.9-41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities-79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-26T11:23:03.125Z</modification><creation>2025-04-06T13:42:08.186Z</creation></dates><accession>S-EPMC10975469</accession><cross_references><pubmed>38543880</pubmed><doi>10.3390/vaccines12030246</doi></cross_references></HashMap>